CKPT — Checkpoint Therapeutics Share News
0.000.00%
Last trade - 00:00- $370.71m
- $337.66m
- $0.04m
Checkpoint Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Checkpoint Therapeutics Inc expected to post a loss of 15 cents a share - Earnings Preview
Checkpoint Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Checkpoint Therapeutics Inc expected to post a loss of 30 cents a share - Earnings Preview
Brief: Checkpoint Therapeutics Announces Biologics License Application Resubmission For Cosibelimab
Brief: Checkpoint Therapeutics Announces Alignment With FDA
Checkpoint Therapeutics Inc expected to post a loss of 27 cents a share - Earnings Preview
Brief: Checkpoint Therapeutics Says Got Letter From Nasdaq Confirming It Was Not In Compliance With Board Independence Rule
U.S. RESEARCH ROUNDUP-Cencora, Heico, Masonite International
U.S. STOCKS ON THE MOVE-Biomerica, Netflix, SunPower
U.S. STOCKS ON THE MOVE-Occidental Petroleum, Scorpio Tankers, ZimVie
U.S. STOCKS ON THE MOVE-Micron, PGT Innovations, Adobe
Checkpoint Therapeutics plunges after FDA declines to approve skin cancer therapy
US FDA declines to approve Checkpoint Therapeutics' skin cancer therapy (updated)
US FDA declines to approve Checkpoint Therapeutics' skin cancer therapy
Brief: US FDA Issues Complete Response Letter For Cosibelimab
Brief: Checkpoint Therapeutics Strengthens Intellectual Property Protection For Cosibelimab With New U.S. Patent Issuance
Fortress Biotech shares plunge after highly dilutive offering
Brief: Checkpoint Therapeutics Announces Publication Of Cosibelimab Pivotal Trial Results